[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Belay et al., 2018 - Google Patents

Bacteriophages and phage products: Applications in medicine and biotechnological industries, and general concerns

Belay et al., 2018

View HTML
Document ID
13924539806467979622
Author
Belay M
Sisay T
Wolde T
Publication year
Publication venue
Scientific Research and Essays

External Links

Snippet

Since their discovery in 1928 antibiotics have transformed medicine and saved millions of lives; however, the current global appearance of antibiotic resistance and absence of new antibiotics commercialization to the health sector return to the post-antibiotic era. Today …
Continue reading at academicjournals.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Bacteriophages
    • C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Bacteriophages
    • C12N2795/10011—Bacteriophages dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0291—Yersinia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Bacteriophages
    • C12N2795/00041—Use of virus, viral particle or viral elements as a vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display

Similar Documents

Publication Publication Date Title
Rehman et al. The dawn of phage therapy
Dąbrowska et al. Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies
Weber-Dąbrowska et al. Bacteriophage procurement for therapeutic purposes
Harada et al. Biotechnological applications of bacteriophages: State of the art
Hashempour-Baltork et al. Drug resistance and the prevention strategies in food borne bacteria: an update review
Carvalho et al. Bacteriophages and their derivatives for the treatment and control of food-producing animal infections
Sarhan et al. Phage approved in food, why not as a therapeutic?
El-Shibiny et al. Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria
Elbreki et al. Bacteriophages and their derivatives as biotherapeutic agents in disease prevention and treatment
Reuter et al. Approaches to optimize therapeutic bacteriophage and bacteriophage-derived products to combat bacterial infections
Viertel et al. Viruses versus bacteria—novel approaches to phage therapy as a tool against multidrug-resistant pathogens
Lu et al. The next generation of bacteriophage therapy
Anyaegbunam et al. The resurgence of phage-based therapy in the era of increasing antibiotic resistance: from research progress to challenges and prospects
Atterbury Bacteriophage biocontrol in animals and meat products
Moradpour et al. Modified phages: novel antimicrobial agents to combat infectious diseases
Xu Phage and phage lysins: New era of bio‐preservatives and food safety agents
Saha et al. Ameliorating the antimicrobial resistance crisis: phage therapy
Heselpoth et al. Enzybiotics: endolysins and bacteriocins
Keary et al. Bacteriophages and their endolysins for control of pathogenic bacteria
Aslam et al. Bacteriophage proteome: insights and potentials of an alternate to antibiotics
Brüssow Infection therapy: the problem of drug resistance–and possible solutions
Huang et al. Phages and their lysins: Toolkits in the battle against foodborne pathogens in the postantibiotic era
Belay et al. Bacteriophages and phage products: Applications in medicine and biotechnological industries, and general concerns
Sahu et al. Bacteriophages concept and applications: A review on phage therapy
Gamachu et al. Review of bacteriophage and its applications